Study participants with untreated diabetes were significantly more likely to be male, older, currently smoking, have lower HDL cholesterol levels, higher BMI, non-HDL cholesterol levels, and systolic blood pressure….
Read More »Long-term Effects of Type 2 Diabetes Screening
Does screening help reduce the risk of cardiovascular disease for type 2 diabetes patients?… Previous studies have shown that diabetes screening can reduce the risk of cardiovascular disease (CVD) and myocardial infarction. In addition, diabetes screening also helps in detecting and changing unhealthy behaviors. However, self-rated health is often overlooked …
Read More »Stem Cell Therapy Promising for Type 2 Diabetes
Human embryonic stem cell therapy was recently shown to reverse type 1 diabetes in mice, and now new mouse studies suggest a role for stem cells in the treatment of type 2 diabetes… Obese, diabetic mice treated with a combination of transplanted stem cell-derived pancreatic progenitor cells and insulin-sensitizing drugs …
Read More »Sitagliptin/Simvastatin Combo Tablet for T2DM and Hypercholesterolemia
Sitagliptin/Simvastatin (Juvisync) might be a good option for diabetic patients who want to improve glycemic control and lower cholesterol levels…
Read More »Years Lost and Medical Care Expenditures Associated with Diabetes
Diabetes can have an impact on life expectancy and health expenditures…
Read More »BMI and Stroke Risk among Type 2 Diabetes Patients
There might be an association between obesity with incidence of stroke among type 2 diabetic patients… Diabetes mellitus and obesity are the most common conditions that increase the risk of stroke in the general population. However, not many studies focused on the association between obesity and cardiovascular disease risk among …
Read More »Eylea (aflibercept)
FDA Approves Aflibercept for Diabetic Retinopathy in Patients with Diabetic Macular Oedema. The US Food and Drug Administration (FDA) expanded the approved use for aflibercept (Eylea) injection to treat diabetic retinopathy in patients with diabetic macular oedema (DME). Aflibercept is administered by a physician as an injection into the …
Read More »Insulin Resistance – A Survival Mechanism Gone Awry, Part 1
With this week’s Homerun Slides, we start a short new series on Insulin Resistance put together by Dr. Stanley Schwartz. We begin with a quick overview of the traditional view of the natural history of diabetes as compared to Dr. Schwartz’s newer beta-cell centric model…. To download the complete set …
Read More »Practical Diabetes Care, 3rd Ed., Excerpt #8: Pharmacological Treatment of Hyperglycemia Part 1 of 2
David Levy, MD, FRCP Introduction The pharmacological management of blood glucose in type 2 diabetes remains the most contentious area of diabetes management, and although until relatively recently in the USA the only agents to treat blood glucose were insulin and sulphonylureas, this limited repertoire in no way inhibited the controversy, …
Read More »Results of Study on Diet Sodas Should be Treated with Caution Due to Study Limitations
The recent study “Diet Soda Intake Is Associated with Long-Term Increases in Waist Circumference in a Biethnic Cohort of Older Adults: The San Antonio Longitudinal Study of Aging (SALSA)”1 suffers from several limitations, which likely confound the study’s conclusions. The authors note that the waist circumference (abdominal fat) findings were not …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.